Ausgabe 3/2024
Inhalt (31 Artikel)
When Less is More: Drug-Coated Balloons Threaten a Paradigm Revolution
Bilal Alqam, James C Blankenship
Open Issues in the Management of Otcagerian Patients with Atrial Fibrillation and Chronic Kidney Disease: Are we Ready for Left Atrial Appendage Occlusion (LAAO) as First-Line Therapy for Thromboembolic Risk Prevention?
Francesco Condello, Angelica Cersosimo, Riccardo Cappato, Paolo Pagnotta
Impairment of Vascular Homeostasis in Acute Heart Failure: Enter the Monocyte?
Saifei Liu, Indy AJ Lawrie, Bibi Rabia, John D. Horowitz
Beyond Hepatoprotection—The Cardioprotective Effects of Bicyclol in Diabetes
Arun Samidurai, Rakesh C. Kukreja
C/EBP Homologous Protein: A Potential Therapeutic Target for Atherosclerosis Treatment?
Jinjiao Shan, Sanlong Liu, Ying Liu, Jingguang Zhu
Possible Cardioprotective Effects of Lactate Infusion After Cardiac Arrest or Prolonged Myocardial Ischemia
Takashi Koyama
IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area
Yanyan Ye, Fangyuan Chang, Yingchun Xu
The Potential Cardiovascular Benefits of COVID-19 Vaccination: Lessons from Influenza and Emerging Evidence
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
MicroRNA-92a in Cardiovascular Disease: An Insufficiently Explored and Controversial Research Area
Jin-Zhen Cui, Yue-Min Yuan, Yan-Yu Lin
Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin
Tugba Ertan-Bolelli, Kayhan Bolelli, Sıtkı Doga Elçi, F. Burcu Belen-Apak
Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial
Kishal Lukhna, Helison R. P. do Carmo, Alejandro Rossell Castillo, Sean M. Davidson, Hayli Geffen, Sara Giesz, Pelin Golforoush, Ticiane Gonçalez Bovi, Diana Gorag, Alan Salama, Aqeela Imamdin, Siavash Kalkhoran, Sandrine Lecour, Mauricio W. Perroud Jr., Mpiko Ntsekhe, Andrei C. Sposito, Derek M. Yellon
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study
Roy O. Mathew, Mandeep S. Sidhu, Charanjit S. Rihal, Ryan Lennon, Mohammed El-Hajjar, Neil Yager, Radmila Lyubarova, Khaled Abdul-Nour, Steven Weitz, D. Fearghas O’Cochlain, Vishakantha Murthy, Justin Levisay, Kevin Marzo, John Graham, Vlad Dzavik, Derek So, Shaun Goodman, Yves D. Rosenberg, Naveen Pereira, Michael E. Farkouh
Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials
Qingtao Hou, Yuqin Chen, Yingxiao Zhang, Caishuang Pang
Left Bundle Branch Area Pacing versus Biventricular Pacing for Cardiac Resynchronization Therapy on Morbidity and Mortality
Yixiu Liang, Zilong Xiao, Xi Liu, Jingfeng Wang, Ziqing Yu, Xue Gong, Hongyang Lu, Shengwen Yang, Min Gu, Lei Zhang, Minghui Li, Lei Pan, Xiao Li, Xueying Chen, Yangang Su, Wei Hua, Junbo Ge
Left Ventricular Thrombus Management After Acute Myocardial Infarction in Clinical Practice: Results from LEVITATION Survey and Narrative Review
Luca A. F. Di Odoardo, Matteo Bianco, Iván J. Núñez Gil, Italo G. Motolese, Alessandra Chinaglia, Marco Vicenzi, Stefano Carugo, Giulio G. Stefanini, Enrico Cerrato
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials
Wolfgang Koenig, Lorena Garcia Conde, Ulf Landmesser, Lawrence A. Leiter, Kausik K. Ray, Gregory G. Schwartz, R Scott Wright, Jackie Han, Frederick J. Raal
Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease
Wei-Chieh Lee, Ting-Wei Liao, Tien-Yu Chen, Hsiu-Yu Fang, Yen-Nan Fang, Huang-Chung Chen, Yu-Sheng Lin, Shang-Hung Chang, Mien-Cheng Chen
The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients
Weiguo Fan, Hualong Liu, Yang Shen, Kui Hong
Mitogen-Activated Protein Kinases Mediate Adventitial Fibroblast Activation and Neointima Formation via GATA4/Cyclin D1 Axis
Jing Chen, Jin-Qiu Wei, Mo-Na Hong, Zhong Zhang, Han-Dan Zhou, Yuan-Yuan Lu, Jia Zhang, Yue-Tong Guo, Xin Chen, Ji-Guang Wang, Ping-Jin Gao, Xiao-Dong Li
Vaccine Targeting Alpha 1D-Adrenergic Receptor Improved Metabolic Syndrome in Mice
Xin Li, Wenrui Ma, Yanzhao Zhou, Chang Li, Dingyang Shi, Wenlong Kuang, Jiacheng Wu, Yuhua Liao, Zhihua Qiu, Zihua Zhou
Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress
Lingxi Zhang, Chenghong Hu, Bo Jin, Bin Bai, Jing Liao, Leiming Jin, Minxiu Wang, Weiwei Zhu, Xuedan Wu, Li Zheng, Xuelian Xu, Yongsheng Jiang, Yi Wang, Ying He
IL-33 Suppresses the Progression of Atherosclerosis via the ERK1/2-IRF1-VCAM-1 Pathway
Zhang Qian, Feng Shaofang, Chen Chen, Shi Chunhua, Wang Nan, Liu Chao
PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study
Umut Kocabaş, Isil Ergin, Veysel Yavuz, Selda Murat, Ibrahim Özdemir, Ömer Genç, Cihan Altın, Haşim Tüner, Bengisu Keskin Meriç, Ali Çoner, Elif İlkay Yüce, Bedrettin Boyraz, Onur Aslan, Ahmet Dal, Taner Şen, Ersin İbişoğlu, Aslan Erdoğan, Mehmet Özgeyik, Mevlüt Demir, Ziya Gökalp Bilgel, Büşra Güvendi Şengör, Örsan Deniz Urgun, Mustafa Doğduş, Deniz Dilan Naki Tekin, Sinem Çakal, Sercan Çayırlı, Arda Güler, Dilay Karabulut, Onur Dalgıç, Osman Uzman, Bektaş Murat, Şeyda Şahin, Umut Karabulut, Tarık Kıvrak, Muharrem Said Coşgun, Ferhat Özyurtlu, Mehmet Kaplan, Emre Özçalık, Hakan Gökalp Uzun, Süleyman Kalaycı, Gülsüm Bingöl, Özge Özden, Gülsüm Meral Yılmaz Öztekin, Ayça Gümüşdağ, Meltem Altınsoy, Faruk Aydınyılmaz, Mehtap Yeni, Halil İbrahim Biter, Ümit Yaşar Sinan, Veysel Özgür Barış, Özcan Vuran, Sefa Okar
Correction to: Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants In Patients With Atrial Fibrillation: The ANATOLIA-AF Study
Umut Kocabaş, Isil Ergin, Veysel Yavuz, Selda Murat, Ibrahim Özdemir, Ömer Genç, Cihan Altın, Haşim Tüner, Bengisu Keskin Meriç, Ali Çoner, Elif İlkay Yüce, Bedrettin Boyraz, Onur Aslan, Ahmet Dal, Taner Şen, Ersin İbişoğlu, Aslan Erdoğan, Mehmet Özgeyik, Mevlüt Demir, Ziya Gökalp Bilgel, Büşra Güvendi Şengör, Örsan Deniz Urgun, Mustafa Doğduş, Deniz Dilan Naki Tekin, Sinem Çakal, Sercan Çayırlı, Arda Güler, Dilay Karabulut, Onur Dalgıç, Osman Uzman, Bektaş Murat, Şeyda Şahin, Umut Karabulut, Tarık Kıvrak, Muharrem Said Coşgun, Ferhat Özyurtlu, Mehmet Kaplan, Emre Özçalık
The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Jeffrey Triska, Faris Haddadin, Luai Madanat, Ahmad Jabri, Marilyne Daher, Yochai Birnbaum, Hani Jneid
Influence of Genetic and Epigenetic Factors of P2Y12 Receptor on the Safety and Efficacy of Antiplatelet Drugs
Dorota Danielak, Kornel Pawlak, Franciszek Główka, Marta Karaźniewicz-Łada
Direct Oral Anticoagulants: Navigating Through Clinical Challenges
Maria Ioannou, Elena Leonidou, Ioanna Chaziri, Angeliki Mouzarou
Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension
Justin K. Lui, Ruchika A. Sangani, Kari R. Gillmeyer, Jasmine Vakhshoorzadeh, Marcin A. Trojanowski, Andreea M. Bujor, Deepa M. Gopal, Renda Soylemez Wiener, Michael P. LaValley, Elizabeth S. Klings
Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis‑Related Pulmonary Hypertension
Justin K. Lui, Ruchika A. Sangani, Kari R. Gillmeyer, Jasmine Vakhshoorzadeh, Marcin A. Trojanowski, Andreea M. Bujor, Deepa M. Gopal, Renda Soylemez Wiener, Michael P. LaValley, Elizabeth S. Klings